Global Etoricoxib Intermediate Market Insights, Forecast to 2025

Global Etoricoxib Intermediate Market Insights, Forecast to 2025

  • QYResearch
  • June 2019
  • Pharmaceutical
  • 117 pages

Report Description

1
1
Etoricoxib is a non-steroidal anti-inflammatory drug (NSAID) that explicitly targets enzymes responsible for inflammation and pain namely cyclooxygenase-2 and COX-2.
Some of the NSAIDs can be used in a single dose to treat various types of pain; it can also be used for post-surgical pains.
The global Etoricoxib Intermediate market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Etoricoxib Intermediate market based on company, product type, end user and key regions.

This report studies the global market size of Etoricoxib Intermediate in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Etoricoxib Intermediate in these regions.
This research report categorizes the global Etoricoxib Intermediate market by top players/brands, region, type and end user. This report also studies the global Etoricoxib Intermediate market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bayer
Novacap
Abbott
Pfizer
Geri-Care
Perrigo
Kopran
Merck
Sun Pharmaceutical
GlaxoSmithKline

Market size by Product
n-House Manufacturing
Contract Manufacturing Organizations
Market size by End User
Rheumatoid Arthritis
Psoriatic Arthritis
Osteoarthritis
Ankylosing Spondylitis
Chronic Low Back Pain
Acute Pain
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Etoricoxib Intermediate market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Etoricoxib Intermediate market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Etoricoxib Intermediate companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Etoricoxib Intermediate submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Etoricoxib Intermediate are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Etoricoxib Intermediate market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Have query on this report?

Make an Enquiry
Table of Contents
1 Study Coverage
1.1 Etoricoxib Intermediate Product
1.2 Market Segments
1.3 Key Manufacturers Covered
List of Tables and Figures
Figure Etoricoxib Intermediate Product Picture
Table Etoricoxib Intermediate Market Segments
Table Key Manufacturers Etoricoxib Intermediate Covered
Table Global Etoricoxib Intermediate Market Size Growth Rate by Product 2019-2025 (MT) & (Million US$)
Figure Global Etoricoxib Intermediate Sales Market Share by Product 2014-2025

Success Stories

Our Clients

Tell Us What You Need and We’ll Get Back with the Best Solutions Available.

*
*
*

get in touch

Location :

State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States

Call Us :

US/Canada toll free : 866-997-4948

Tel : +1-518-621-2074